API
< Back to all clusters
[HEALTH] · Bulgaria · 12 sources

started · updated

Bulgaria faces influenza vaccine shortage and supply delays

Bulgaria is facing a significant shortage of influenza vaccines for the 2026/2027 season. The pharmaceutical company Viatris has announced that the Influvac vaccine will not be available for free sale in pharmacies. Instead, all available doses will be prioritized for national immunization programs targeting high-risk groups, including children and adults over 65.

Manufacturers attribute the delay to the World Health Organization’s late determination of the required virus strains, alongside technological issues and delays in securing critical production materials. These production difficulties are reportedly affecting multiple international markets, not just Bulgaria.

While nasal vaccines for children are currently available, injectable supplies are limited. For the free national programs, approximately 450,000 doses are planned for seniors and roughly 50,000 for children. For the open market, only about 70,000 injectable doses are expected to arrive around mid-November, a figure significantly lower than previous years. This shortage has forced some citizens to travel to neighboring Greece to seek vaccination.

Entities

Bulgarian Ministry of Health · Bulgarian Pharmaceutical Union · Influvac · Katya Ivkova · Ministry of Health · Viatris · World Health Organization

Sources